These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8428685)

  • 21. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and properties of nine human ovarian adenocarcinoma cell lines.
    Langdon SP; Lawrie SS; Hay FG; Hawkes MM; McDonald A; Hayward IP; Schol DJ; Hilgers J; Leonard RC; Smyth JF
    Cancer Res; 1988 Nov; 48(21):6166-72. PubMed ID: 3167863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
    Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
    Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.
    Yabushita H; Ueno N; Sawaguchi K; Higuchi K; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):888-94. PubMed ID: 2794621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: a calcitonin-responsive line derived from a rare tumor type.
    Upchurch KS; Parker LM; Scully RE; Krane SM
    J Bone Miner Res; 1986 Jun; 1(3):299-304. PubMed ID: 2845729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of cell lines established from human colorectal carcinoma.
    Park JG; Oie HK; Sugarbaker PH; Henslee JG; Chen TR; Johnson BE; Gazdar A
    Cancer Res; 1987 Dec; 47(24 Pt 1):6710-8. PubMed ID: 3479249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CA 125 and TPA as markers in ovarian carcinoma.
    Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
    Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
    [No Abstract]   [Full Text] [Related]  

  • 28. [Establishment and characterization of a human chorionic gonadotropin (hCG) producing cell line (RTSG) from an ovarian epithelial cancer].
    Udagawa Y; Nozawa S; Chin K; Sakayori M; Mikami M; Ohta K; Tsukazaki K; Kiguchi K; Iizuka R
    Hum Cell; 1990 Mar; 3(1):70-5. PubMed ID: 2083225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: morphologic and embryologic considerations.
    Becker JL; Prewett TL; Spaulding GF; Goodwin TJ
    J Cell Biochem; 1993 Mar; 51(3):283-9. PubMed ID: 8501130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system.
    Conover CA; Hartmann LC; Bradley S; Stalboerger P; Klee GG; Kalli KR; Jenkins RB
    Exp Cell Res; 1998 Feb; 238(2):439-49. PubMed ID: 9473353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment of a cisplatin-resistant human ovarian cancer cell line].
    Sasa H; Hisano A; Ishii K; Hirata J; Kikuchi Y; Nagata I; Senoo A; Aida S; Tamai S; Sugita M
    Hum Cell; 1993 Jun; 6(2):106-13. PubMed ID: 8217948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
    Bar JK; Harlozińska A
    Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.
    Möbus VJ; Gerharz CD; Weikel W; Merk O; Dreher L; Kreienberg R; Moll R
    Gynecol Oncol; 2001 Dec; 83(3):523-32. PubMed ID: 11733966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 35. Collagenase expression in ovarian cancer cell lines.
    Moore DH; Allison B; Look KY; Sutton GP; Bigsby RM
    Gynecol Oncol; 1997 Apr; 65(1):78-82. PubMed ID: 9103395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human ovarian carcinoma cells maintained on extracellular matrix versus plastic.
    Crickard K; Crickard U; Yoonessi M
    Cancer Res; 1983 Jun; 43(6):2762-7. PubMed ID: 6850590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of human ovarian carcinoma cell lines.
    Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
    Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The dose-response of cell proliferation and secretion of CA125 II antigen to follicle stimulating hormone in ovarian cancer cell lines].
    Zhu M; Wu Q; Ge B
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):225-6. PubMed ID: 10682470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice.
    Schumacher U; Adam E; Dietl J; Horny HP
    Exp Mol Pathol; 1997 Apr; 64(2):103-13. PubMed ID: 9316588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.